KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $207,000 | -60.2% | 10,800 | -87.6% | 0.02% | -33.3% |
| Q2 2019 | $520,000 | -66.7% | 86,951 | -67.5% | 0.04% | -50.0% |
| Q1 2019 | $1,563,000 | -4.1% | 267,800 | +54.0% | 0.07% | -35.7% |
| Q4 2018 | $1,629,000 | +54.1% | 173,869 | +180.0% | 0.11% | +83.6% |
| Q3 2018 | $1,057,000 | -28.5% | 62,100 | +95.3% | 0.06% | -72.3% |
| Q2 2014 | $1,479,000 | +182.3% | 31,800 | +87.1% | 0.22% | +171.6% |
| Q1 2014 | $524,000 | -5.2% | 17,000 | -29.8% | 0.08% | -15.6% |
| Q4 2013 | $553,000 | – | 24,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |